𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reinforcing effect of the D1dopamine agonist SKF 81297 in rhesus monkeys

✍ Scribed by Michael R. Weed; Kimberly E. Vanover; William L. Woolverton


Publisher
Springer
Year
1993
Tongue
English
Weight
281 KB
Volume
113
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The dopamine D1 agonist SKF 81297 and th
✍ R. J. Vermeulen; Dr. B. Drukarch; M. C. R. Sahadat; C. Goosen; E. C. Wolters; J. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 902 KB

## Abstract At present, the pharmacotherapy of Parkinson's disease (PD) consists mainly of L‐dihydroxyphenylalanine (L‐DOPA) and/or dopamine D~2~ receptor agonist. However, in general the clinical efficacy of D~2~ agonists is less than that of L‐DOPA. Therefore, attention is being focussed on the r

Effect of cocaine self-administration on
✍ Rodney J. Moore; Sharon L. Vinsant; Michael A. Nader; Linda J. Porrino; David P. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

An array of evidence indicates that long-term exposure to cocaine alters several components of the brain dopamine system. Because the release of dopamine in the nucleus accumbens (NAc) has been implicated in mediating the reinforcing effects of cocaine, changes in dopamine function can have profound